According to market observers, unlisted shares of Anthem Biosciences Ltd are currently trading at Rs 733 against its upper ...

Anthem Biosciences’ IPO puts the spotlight on India’s contract drug manufacturing sector, as investor appetite swells and global firms diversify away from China.

Divi Resorts is bringing back its popular Kids Stay & Eat Free program for a limited time! On all-inclusive stays, kids 12 ...

Anthem ticks all the boxes. But with lofty valuations and limited margin headroom, analysts warn the IPO may not deliver ...

Anthem Biosciences is a leading player in the fast growing CRDMO (Contract Research, Development and Manufacturing ...

Anthem Biosciences IPO on Day 2 with moderate success, price band ₹540-570, 35% reserved for retail investors.

The shares of one of India's leading API manufacturers, engaged in the production and export of APIs, intermediates, and ...

Despite a generally weak market, the Nifty Pharma index advanced by 0.35% on Monday, with Laurus Labs Ltd. and Mankind Pharma Ltd. leading the gains.

Divi's Labs makes active pharmaceutical ingredients for Entresto for Novartis, which contributes nearly 8% to Hyderabad-based ...

Brokerage firm IIFL has warned that due to this development, Divi's Laboratories' annual Earnings Before Interest, Tax, ...

This marks the highest medal haul by any nation at the event, further solidifying India’s status as a global chess powerhouse ...

Anthem Biosciences IPO: The Bengaluru-based company, Anthem Biosciences, has secured Rs 1,016 crore from anchor investors ...